Pyrrolo [1,2-a]quinoxaline derivatives as adenosine A3 receptor modulators and uses thereof

Details for Australian Patent Application No. 2006328934 (hide)

Owner Faust Pharmaceuticals

Inventors Schann, Stephan; Gardan, Sophie; Mayer, Stanislas

Agent Griffith Hack

Pub. Number AU-A-2006328934

PCT Pub. Number WO2007/071379

Priority 05292739.9 19.12.05 EP

Filing date 19 December 2006

Wipo publication date 28 June 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071379 Priority application(s): WO2007/071379

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328943-Improved method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer

2006328930-Antiperspirant compositions